The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Book
AHRMM created this book for engaged and motivated supply chain leaders in the making.
On-Demand Educational Webinars
As hospitals restructure to gain sustainability in an era of reform, it is crucial for supply chain leaders to work collaboratively within health…
On-Demand Educational Webinars
Tracking surgical supplies is a challenge. Average returns for picked supplies is low, O.R. in-and-out traffic to retrieve items is high, and…
On-Demand Educational Webinars
Outsourcing of hospital functions is a common and growing practice in the U.S. and comprises on average 25% of total non-labor spend in hospitals.…
Webcast
In this 3-part series, learn how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration.
On-Demand Educational Webinars
We all question whether some health care supply chains outperform others, which competencies separate those supply chain professionals from t